Edward Lifesciences Archives - Cardiac Vascular News

Tag: Edward Lifesciences

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Financial April 27, 2022 by Ken Dropiewski 0 comments

IRVINE, Calif., April 26, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022. First Quarter Highlights and Outlook Q1 sales grew 10 percent to $1.34 billion; underlying1 13 percent Q1 TAVR sales grew 11 percent; underlying 14 […]

Continue Reading →

Edwards Receives FDA Approval for SAPIEN 3 with Alterra Prestent for Transcatheteter Pulmonic Valve Replacement

Coronary/Structural Heart Regulatory December 20, 2021 by Ken Dropiewski 0 comments

IRVINE, Calif., Dec. 20, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) […]

Continue Reading →

Tag: Edward Lifesciences

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Edwards Receives FDA Approval for SAPIEN 3 with Alterra Prestent for Transcatheteter Pulmonic Valve Replacement

Recent

BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure

Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

Popular

Subscribe to Blog via Email